Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept

PURPOSE: Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth factor (VEGF) receptor–IgG fusion protein, has been developed as a new drug for ocular neovascularization and macular edema. The present study aims to clarify the changes in conbercept levels, VEGF, and intraocular...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Vis
Autors principals: Du, Liping, Peng, Hui, Wu, Quan, Zhu, Meidong, Luo, Delun, Ke, Xiao, Yang, Peizeng, Lei, Bo
Format: Artigo
Idioma:Inglês
Publicat: Molecular Vision 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4337358/
https://ncbi.nlm.nih.gov/pubmed/25737631
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars